Prostate cancer risk: The significance of age-related differences in PSA velocity between men with and without biopsy-proven prostate cancers

被引：0
|
作者：
Bektic, Jasmin
Pelzer, Alexandre E.
Schaefer, Georg
Bartsch, Georg
Horninger, Wolfgang
机构：
来源：
JOURNAL OF UROLOGY | 2007年 / 177卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：580 / 580
页数：1
相关论文
共 50 条
  • [31] Age-related reference levels of serum prostate-specific antigen among taiwanese men without clinical evidence of prostate cancer
    Lin, Kuo-Jen
    Pang, See-Tong
    Chang, Ying-Hsu
    Wu, Chun-Te
    Chuang, Kun-Lung
    Chuang, Heng-Chang
    Chuang, Cheng-Keng
    INTERNATIONAL JOURNAL OF UROLOGY, 2010, 17 : A166 - A166
  • [32] EVALUATION OF VARIETY AND PERFORMANCE BETWEEN PSA ASSAYS AND PHI IN A CLINICAL COHORT OF MEN UNDERGOING PROSTATE BIOPSY FOR SUSPECTED PROSTATE CANCER
    Kaufmann, Basil
    Pellegrino, Paloma
    Lautenbach, Noemie
    Spanaus, Katharina
    von Eckardstein, Arnold
    Hermanns, Thomas
    Poyet, Cedric
    JOURNAL OF UROLOGY, 2022, 207 (05): : E189 - E189
  • [33] Reference Ranges of Age-Related Prostate-Specific Antigen in Men without Cancer from Beijing Area
    Liu, Xin
    Wang, Jie
    Zhang, Shun-Xin
    Lin, Qian
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2013, 42 (11) : 1216 - 1222
  • [34] Age-specific risk of prostate cancer if PSA is between the median value and commonly used biopsy thresholds.
    Kundu, SD
    Roehl, KA
    Antenor, JAV
    Catalona, WJ
    Nadler, RB
    JOURNAL OF UROLOGY, 2005, 173 (04): : 258 - 258
  • [35] Prostate Specific Antigen Velocity Risk Count Predicts Biopsy Reclassification for Men with Very Low Risk Prostate Cancer EDITORIAL COMMENT
    Ploussard, Guillaume
    JOURNAL OF UROLOGY, 2014, 191 (03): : 637 - 637
  • [36] Association of PSA Velocity with Disease Progression and Metastases in Men with Low Risk Prostate Cancer on Active Surveillance
    Nelson, T. J.
    Deka, R.
    Nalawade, V.
    Chen, Q.
    Courtney, P. T.
    Salans, M. A.
    Cherry, D. R.
    Luterstein, E.
    Parsons, J. K.
    Kader, K.
    Stewart, T. F.
    Mell, L. K.
    Murphy, J. D.
    Rose, B. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E881 - E881
  • [37] IS THE ASSOCIATION BETWEEN DUTASTERIDE USE AND PROSTATE CANCER RISK DIFFERENT IN MEN WITH A FAMILY HISTORY OF BREAST OR PROSTATE CANCERS?
    Thomas, Jean-Alfred
    Gerber, Leah
    Moreira, Daniel M.
    Banez, Lionel L.
    Andriole, Gerald L.
    Freedland, Stephen J.
    JOURNAL OF UROLOGY, 2012, 187 (04): : E779 - E779
  • [38] THE PROSTATE CANCER PREVENTION TRIAL (PCPT) RISK CALCULATOR AND THE RELATIONSHIP BETWEEN PSA AND BIOPSY OUTCOME
    Vickers, A. J.
    Sjoberg, D.
    Ankerst, D. P.
    Tangen, C. M.
    Goodman, P. J.
    Thompson, I. M., Jr.
    JOURNAL OF UROLOGY, 2012, 187 (04): : E492 - E493
  • [39] Midlife baseline PSA as a predictor of lethal prostate cancer: Racial differences between black and white men
    Chiarelli, G.
    Davis, M.
    Stephens, A.
    Finati, M.
    Cirulli, G.
    Morrison, C.
    Sood, A.
    Carrieri, G.
    Briganti, A.
    Montorsi, F.
    Lughezzani, G.
    Buffi, N.
    Rogers, C.
    Abdollah, F.
    EUROPEAN UROLOGY, 2024, 85 : S54 - S54
  • [40] Serum prostate specific antigen (PSA) levels in men without clinical evidence of prostate cancer: Age-specific reference ranges for total PSA, free PSA and percent free PSA.
    Kalish, LA
    McKinlay, JB
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1999, 149 (11) : S65 - S65
12345